Korean firm Boditech Med sets up manufacturing unit at Reliance's MET City in Haryana's Jhajjar
Inauguration ceremony of Boditech Med’s state-of-the-art facility at MET City
MET City is now home to more than 600 companies from 10 countries, including six from South Korea alone.
South Korean company Boditech Med has on April 4 inaugurated a state-of-the-art manufacturing facility at Reliance's MET City in Haryana's Jhajjar. The MNC, which is known for its solutions in the in vitro diagnostics (IVD) space, has set up the unit under its India subsidiary Boditech Med India Pvt. Ltd.
Model Economic Township Limited (METL), which is a wholly-owned subsidiary of Reliance Industries Limited, said, "This marks a significant milestone in MET City’s growing status as a preferred destination for global medtech companies and further strengthens its position as India’s leading greenfield smart sustainable industrial township."
The statement added that MET City continues to be a "beacon for multinational corporations". It is now home to more than 600 companies from 10 countries, including six from South Korea alone.
It further said that Boditech Med's new manufacturing facility is in line with the Government of India's Make in India and Atmanirbhar Bharat initiatives.
MET City CEO SV Goyal said, "We're pleased to welcome Boditech Med to MET City's growing roster of global companies. As a leading Greenfield Smart Sustainable City with companies from 10 countries utilising our Plug-n-Play infrastructure, MET City has become a destination of choice for diverse industries. Boditech Med's state-of-the-art facility strengthens our position as an emerging hub for medical device manufacturing, and we look forward to welcoming more South Korean enterprises to our township at Jhajjar as India's industrial landscape continues to evolve. Boditech Med’s investment is poised to create local employment, empower small businesses, and position MET City as a key node in the global medical devices value chain."
Boditech Med CEO and Chairman Eui-Yul Choi said, "India represents both a crucial market and an emerging global manufacturing hub for medical devices. The country's supportive policy framework and growing healthcare infrastructure make it an ideal location for our expansion as we strengthen our commitment to the Indian market."